A Medical Device Daily

Radiation Therapy Services (RTS; Fort Myers, Florida) last week reported that James Weeks, an independent director of its board and a member of its audit and compensation committees, passed away unexpectedly on Jan. 8.

Daniel Dosoretz, president/CEO of RTS, said, “We are saddened by the sudden death of James Weeks, and extend our deepest sympathy to his family. James was a valuable member of our board of directors since 2004. He made substantial contributions to our Company and in his 37-year publishing career, including president/CEO of the New York Times regional newspaper group.

“He will be missed, both personally and professionally, leaving a legacy that will not be forgotten.”

RTS notified the Nasdaq stock exchange of Weeks’ death and received a Nasdaq staff deficiency letter on Jan. 10, indicating that due to Weeks’ untimely death, the company no longer complies with Nasdaq’s independent director requirements for continued listing. Nasdaq will provide the company a cure period, which expires July 9, 2007, in order to regain compliance.

RTS is a provider of radiation therapy services to cancer patients.